Stocks · News reference
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $161
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 30, 2026, 3:44 PM
- Checked
- Jul 30, 2026, 3:44 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%
Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance miss and a 19-year high in 30-year yields capped the rebound.
Read original at benzingaLam Research, Xerox, FormFactor, Microsoft And Other Big Stocks Moving Higher On Thursday
Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial results. Xerox, Columbus McKinnon, and other stocks recorded gains.
Read original at benzinga